N/A
Completed N=16
Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy
Pigmented Lesions · Pigmented Skin Lesion · Pigmented Moles · Skin Lesion
Source: ClinicalTrials.gov NCT04566302 ↗
Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcomePrimary: Number of Participants With Quality Skin Images Obtained From SECM Device — 15 Participants
Summary
The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Quality Skin Images Obtained From SECM Device |
15 | — |
Eligibility Criteria
Inclusion Criteria
- Healthy adults
- 18 years of age or older
- Capable of giving informed consent
- Pigmented lesions (such as moles) present on the forearm
Exclusion Criteria
- Unable to provide consent
- Open cuts/sores on the skin, skin infection, or any contagious skin condition
- Pregnant women (according to subject)
- Employees under the direct supervision of the investigator
Data sourced from ClinicalTrials.gov (NCT04566302). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.